Postdoctoral Positions in Antibody Engineering for the Development of Cancer Therapeutics
Postdoctoral positions are available in the laboratory of Drs. E. Sally Ward and Raimund J. Ober at UT Southwestern Medical Center at Dallas. These positions are supported by recently acquired funds from the Cancer Prevention and Research Institute of Texas (www.cprit.state.tx.us). Post-doctoral appointees will work on projects involving the use of antibody engineering approaches to develop therapeutics for cancer that target growth factor receptors and exposed phosphatidylserine (PS). These studies will use a combination of in vitro and in vivo studies in mice to analyze therapeutic efficacy.
These projects have direct relevance to the rapidly expanding use of antibodies in the biopharma industry.
For more information on the research carried out in the laboratory see www4.utsouthwestern.edu/wardlab or publications such as J. Immunol., 187, 1015, 2011; Proc. Natl. Acad. Sci. USA, 106, 2788-2793, 2009; Traffic, 10, 600-614, 2009; Biophys J., 95, 6025-6043, 2008; Proc. Natl. Acad. Sci. USA, 104, 5889-5894, 2007; Proc. Natl. Acad. Sci. USA, 103, 4457-4462, 2006; Nature Biotechnol., 23, 1283-1288, 2005; Proc. Natl. Acad. Sci. USA, 101, 11076-11081, 2004; J. Immunol., 172, 2021-2029, 2004.
Highly motivated individuals with a Ph.D. in any biological area, (bio)engineering, biotechnology, or chemistry should apply. Relevant experience is desirable but is not essential.
If interested, please send CV and names/addresses of at least three referees to E. Sally Ward at firstname.lastname@example.org
UT Southwestern is an Equal Opportunity, Affirmative Action Employer.